As expected, expression of p53 activated genes CDKN1A (p21), MDM2, and BBC3 (Puma) did not correlate with NSCLC patient outcome in TCGA when the cases were separated by p53 status (Supplementary Fig. S1). This evidence concerns the gene TP53 and non-small cell lung carcinoma.